Skip to main content
. 2018 Jun 1;25(6):521–538. doi: 10.5551/jat.44412

Supplementary Table 1. Percent Change in TG (Analysis of Dose-Response Relationship).

Least squares 95%CI P value
Placebo −2.8 ± 4.5 −11.8, 6.2 0.538
Pemafibrate 0.1 mg/day −46.3 ± 2.8 −51.8, −40.9 < 0.001
Pemafibrate 0.2 mg/day −46.8 ± 1.6 −50.0, −43.5 < 0.001
Pemafibrate 0.4 mg/day −51.9 ± 2.0 −55.8, −48.0 < 0.001
Contrast F value P value Adjusted P value*
(−3 −1 1 3) 96.7 < 0.001
(−5 −1 3 3) 98.2 < 0.001 < 0.001
(−3 1 1 1) 96.6 < 0.001

Data are presented as least squares mean ± SE.

*

Multiplicity adjusted (contrast: maximum contrast method)

TG, triglyceride; CI, confidence interval; SE, standard error